CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age21+
SponsorCairo University
About this trial
o evaluate the radiologic proximity of mandibular dental implants placed less than 2 mm from the inferior alveolar canal using cone-beam computed tomography (CBCT), and to determine the relationship between implant-canal distance and the occurrence of postoperative neurosensory disturbances.
Eligibility criteria
Qualifiers
Age ≥ 21 years.
Implants placed in mandibular first/second premolar or molar positions (Froum et al., 2021).
Patients without neurosensory changes following implant placement and healing (Froum et al., 2021).
Patients with neurosensory changes after implant placement, including paresthesia, anesthesia, dysesthesia (and neuralgia where applicable) (Froum et al., 2021).
Disqualifiers
Incomplete records preventing outcome ascertainment (Froum et al., 2021).
Refusal/unavailability of postoperative CBCT when clinically required for evaluation (Froum et al., 2021).
Poor-quality CBCT scans or scatter artifacts interfering with evaluation (Froum et al., 2021).
Contraindications for radiographs (e.g., pregnancy/breastfeeding) in cases where additional imaging would otherwise be clinically required (Froum et al., 2021).
Trial design
Treatments tested in this trial
- nerve approximation group
Treatment groups
100 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov